RNVU1-4
gene geneOn this page
Also known as vU1.4RNU1-102vU1.5RNU1-50
Summary
RNVU1-4 (RNA, variant U1 small nuclear 4, HGNC:48312) is a small nuclear RNA gene on chromosome 1q21.1.
Predicted to enable pre-mRNA 5’-splice site binding activity. Predicted to be involved in mRNA 5’-splice site recognition. Predicted to be part of U1 snRNP.
Source: NCBI Gene 101954264 — RefSeq curated summary.
At a glance
- Gene type: non-coding (snRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48312 |
| Approved symbol | RNVU1-4 |
| Name | RNA, variant U1 small nuclear 4 |
| Location | 1q21.1 |
| Locus type | RNA, small nuclear |
| Status | Approved |
| Aliases | vU1.4, RNU1-102, vU1.5, RNU1-50 |
| Ensembl gene | ENSG00000277610 |
| Ensembl biotype | snRNA |
| Entrez | 101954264 |
| RNAcentral | URS0000681820 — snRNA, 164 nt, 2 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 snRNA
ENST00000612985
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000612985 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003743572 | 120942600 | 120942763 |
Expression profiles
Bgee: expression breadth ubiquitous, 110 present calls, max score 91.17.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2553 / max 283.8331, expressed in 351 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201647 | 1.2553 | 351 |
Top tissues by expression
110 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bone marrow | UBERON:0002371 | 91.17 | gold quality |
| monocyte | CL:0000576 | 89.38 | gold quality |
| leukocyte | CL:0000738 | 88.56 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.17 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.87 | gold quality |
| granulocyte | CL:0000094 | 77.79 | gold quality |
| myometrium | UBERON:0001296 | 76.47 | gold quality |
| blood | UBERON:0000178 | 75.96 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 74.32 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.14 | gold quality |
| fundus of stomach | UBERON:0001160 | 71.94 | gold quality |
| left uterine tube | UBERON:0001303 | 71.93 | gold quality |
| islet of Langerhans | UBERON:0000006 | 71.71 | gold quality |
| stomach | UBERON:0000945 | 70.49 | gold quality |
| corpus callosum | UBERON:0002336 | 70.42 | gold quality |
| lymph node | UBERON:0000029 | 69.80 | gold quality |
| pancreas | UBERON:0001264 | 69.69 | gold quality |
| prefrontal cortex | UBERON:0000451 | 69.44 | gold quality |
| vermiform appendix | UBERON:0001154 | 69.40 | gold quality |
| muscle of leg | UBERON:0001383 | 69.40 | gold quality |
| omental fat pad | UBERON:0010414 | 69.19 | gold quality |
| body of pancreas | UBERON:0001150 | 68.83 | gold quality |
| lung | UBERON:0002048 | 68.48 | gold quality |
| endometrium | UBERON:0001295 | 67.95 | gold quality |
| adipose tissue | UBERON:0001013 | 67.86 | gold quality |
| urinary bladder | UBERON:0001255 | 67.85 | gold quality |
| liver | UBERON:0002107 | 67.84 | gold quality |
| body of stomach | UBERON:0001161 | 67.42 | gold quality |
| left coronary artery | UBERON:0001626 | 66.89 | gold quality |
| tibial artery | UBERON:0007610 | 66.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.59 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (147): RNU1-75P (ENSG00000194297), RNU1-15P (ENSG00000195024), RNU1-58P (ENSG00000199283), RNU1-150P (ENSG00000199361), RNU1-108P (ENSG00000199426), RNU1-62P (ENSG00000199469), RNU1-70P (ENSG00000199488), RNU1-94P (ENSG00000199497), RNU1-14P (ENSG00000199629), RNU1-35P (ENSG00000199652), RNU1-38P (ENSG00000199687), RNU1-76P (ENSG00000199773), RNU1-134P (ENSG00000199805), RNU1-47P (ENSG00000199836), RNU1-72P (ENSG00000199846), RNVU1-22 (ENSG00000199879), RNU1-17P (ENSG00000199892), RNU1-18P (ENSG00000199932), RNU1-19P (ENSG00000200176), RNU1-20P (ENSG00000200184), RNU1-21P (ENSG00000200197), RNU1-22P (ENSG00000200204), RNU1-23P (ENSG00000200231), RNU1-83P (ENSG00000200296), RNU1-49P (ENSG00000200338), RNU1-105P (ENSG00000200340), RNVU1-33 (ENSG00000200597), RNU1-124P (ENSG00000200731), RNU1-31P (ENSG00000200745), RNU1-65P (ENSG00000200789), RNU1-130P (ENSG00000200800), RNU1-32P (ENSG00000200807), RNU1-146P (ENSG00000200885), RNU1-42P (ENSG00000200903), RNU1-7P (ENSG00000200975), RNVU1-34 (ENSG00000200997), RNU1-96P (ENSG00000201033), RNU1-33P (ENSG00000201119), RNU1-151P (ENSG00000201142), RNU1-24P (ENSG00000201155)
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.